News

17 Presentations Highlighting the Clinical Value of Cellvizio® in Gastrointestinal Diseases at the Digestive Disease Week® 2019

16 May 2019

17 accepted abstracts demonstrate growing clinical recognition of Cellvizio® as a necessary tool for real-time endomicroscopy imaging in multiple gastrointestinal indications 

Mauna Kea Technologies today announced the presentation of 17 abstracts supporting Cellvizio® at the Digestive Disease Week® (DDW) Conference, being held on May 18-21, 2019, at the San Diego Convention Center, San Diego, CA, USA. These abstracts focus on Barrett’s esophagus, inflammatory bowel disease, food allergy, pancreatic cyst and other gastrointestinal diseases. Studies are focused on how the use of Cellvizio® potentially impacts patient management and improved outcomes. 

“Real-time in vivo confocal laser endomicroscopy with Cellvizio is once again taking center stage at the Digestive Disease Week® as evidenced by the many high-quality studies presented this year,” said Robert L. Gershon, Chief Executive Officer of Mauna Kea Technologies. “We are excited to see the large number of studies being presented and discussed that demonstrate the potential significant impact of Cellvizio on patient management. It also shows that Cellvizio is a key driver for improved outcomes and reduced healthcare costs in multiple applications such as pancreatic lesions and inflammatory bowel disease, two widely prevalent conditions in great need for advanced technology to help diagnosis and treatment.” 

Highlighted featured presentations: 

  • CONFOCAL LASER ENDOMICROSCOPY CAN PREDICT MAJOR CLINICAL EVENTS WITH VERY HIGH SENSITIVITY IN PATIENTS WITH INFLAMMATORY BOWEL DISEASES 

Presentation # 291 
Sunday, May 19; at 8:00 – 8:15 a.m. PT 
Room 2 Presenting Authors: E. Klenske and T. Rath, University Hospital Erlangen, Erlangen, Germany 

  • CONFOCAL LASER ENDOMICROSCOPY REVEALS DIFFERENTIAL RESPONSE IN PATIENTS WITH ACTIVE ULCERATIVE COLITIS UNDERGOING ANTI-INTEGRIN COMPARED TO ANTI-TNF-ALPHA THERAPY 

Presentation # 292 
Sunday, May 19; at 8:15 – 8:30 a.m. PT 
Room 2 Presenting Author: M. Ellrichmann, University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Germany 

  • A HIGH RATE OF IGE-NEGATIVE FOOD ALLERGIES IN PATIENTS WITH IRRITABLE BOWEL SYNDROME 

Presentation # 946 
Tuesday, May 21; at 11:18 – 11:30 a.m. PT 
Room 24ABC C 
Presenting Author: A. Fritscher-Ravens, University Hospital Schleswig-Holstein, Kiel, Kiel, Germany 

  • EUS-GUIDED MICROFORCEPS BIOPSY AND NEEDLE-BASED CONFOCAL LASER ENDOMICROSCOPY SIGNIFICANTLY IMPROVE THE DIAGNOSTIC YIELD AND HAVE MAJOR IMPACT ON CLINICAL MANAGEMENT OF PANCREATIC CYSTIC LESIONS 

Presentation # 1125 
Tuesday, May 21; at 2:30 – 2:45 p.m. PT 
Room 2 Presenting Authors: R. Cheesman and C. J. DiMaio, Icahn School of Medicine at Mount Sinai, New York 

  • QUALITATIVE DERIVATION AND QUANTITATIVE PREDICTION OF DYPLASIA IN INTRADUCTAL PAPILLARY MUCINOUS NEOPLASMS USING EUS-GUIDED NEEDLE-BASED CONFOCAL LASER ENDOMICROSCOPY 

Presentation # 589 
Monday, May 20; at 10:00 – 10:15 a.m. PT 
Room 26AB Presenting Author: Somashekar G. Krishna, The Ohio State University Medical Center 

Featured poster session:

  • PANCREATIC CYSTIC LESIONS: ACTIVE VERSUS PASSIVE LEARNING AMONG NAIVE OBSERVERS: A CONTROLLED TRIAL FOR DIFFERENTIATING CONFOCAL ENDOMICROSCOPY PATTERNS 

Poster # Su1454 
Sunday, May 19; at 12:00 – 2:00 p.m. PT 
Halls C-E Presenting Author: Somashekar G. Krishna, The Ohio State University Medical Center 

  • DEVELOPMENT OF AN ENDOMICROSCOPIC INDEX TO EVALUATE IN VIVO HISTOLOGICAL HEALING IN ULCERATIVE COLITIS PATIENTS: THE ENHANCE INDEX FROM THE FRENCH SOCIETY OF ENDOSCOPY (SFED) 

Poster # Tu1995 
Tuesday, May 21; at 12:00 – 2:00 p.m. PT 
Halls C-E Presenting Author: G. Rahmi & L. Peyrin-Biroulet, Gastroenterology, Georges Pompidou European Hospital, Paris, France; CHU Nancy, Nancy, France; 

  • APPLICATION OF MACHINE LEARNING AND ARTIFICIAL INTELLIGENCE IN THE DETECTION OF DYPLASIA IN INTRADUCTAL PAPILLARY MUCINOUS NEOPLASMS USING EUS-GUIDED NEEDLE-BASED CONFOCAL LASER ENDOMICROSCOPY 

Poster # Mo2050 
Monday, May 20; at 12:00 – 2:00 p.m. ET 
Hall C-E Presenting Author: Somashekar G. Krishna, The Ohio State University Medical Center 

Visitors are also invited to meet the team at booth #5333 in the Exhibit Hall. 

Latest News

Mauna Kea Technologies Announces Ground-Breaking Positive Clinical Results in Lung Cancer Obtained with Cellvizio 

Mauna Kea Technologies Announces Ground-Breaking Positive Clinical Results in Lung Cancer Obtained with Cellvizio 

Mauna Kea Technologies Announces Endorsement from The American Foregut Society for Payor Policy Coverage of Cellvizio® 

Mauna Kea Technologies Announces Endorsement from The American Foregut Society for Payor Policy Coverage of Cellvizio® 

Mauna Kea Technologies Announces its Sales and Achievements For the Second Quarter 2024

Mauna Kea Technologies Announces its Sales and Achievements For the Second Quarter 2024